- Home
- AUPH vs FPF Comparison
AUPH vs FPF Comparison
Compare AUPH & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- FPF
- Stock Information
- Founded
- AUPH 1993
- FPF 2013
- Country
- AUPH Canada
- FPF United States
- Employees
- AUPH 300
- FPF N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- FPF Trusts Except Educational Religious and Charitable
- Sector
- AUPH Health Care
- FPF Finance
- Exchange
- AUPH Nasdaq
- FPF Nasdaq
- Market Cap
- AUPH 1.2B
- FPF 1.1B
- IPO Year
- AUPH 1999
- FPF N/A
- Fundamental
- Price
- AUPH $8.93
- FPF $18.83
- Analyst Decision
- AUPH Strong Buy
- FPF
- Analyst Count
- AUPH 2
- FPF 0
- Target Price
- AUPH $11.50
- FPF N/A
- AVG Volume (30 Days)
- AUPH 2.1M
- FPF 186.7K
- Earning Date
- AUPH 07-31-2025
- FPF 01-01-0001
- Dividend Yield
- AUPH N/A
- FPF 8.08%
- EPS Growth
- AUPH N/A
- FPF N/A
- EPS
- AUPH 0.27
- FPF N/A
- Revenue
- AUPH $247,295,000.00
- FPF N/A
- Revenue This Year
- AUPH $12.15
- FPF N/A
- Revenue Next Year
- AUPH $18.34
- FPF N/A
- P/E Ratio
- AUPH $33.57
- FPF N/A
- Revenue Growth
- AUPH 29.20
- FPF N/A
- 52 Week Low
- AUPH $5.20
- FPF $13.91
- 52 Week High
- AUPH $10.67
- FPF $18.09
- Technical
- Relative Strength Index (RSI)
- AUPH 57.25
- FPF 58.52
- Support Level
- AUPH $8.73
- FPF $18.71
- Resistance Level
- AUPH $9.37
- FPF $18.83
- Average True Range (ATR)
- AUPH 0.41
- FPF 0.13
- MACD
- AUPH 0.04
- FPF -0.03
- Stochastic Oscillator
- AUPH 77.28
- FPF 65.79
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.